Kensey Nash to Present at the Bank of America 2008 Health Care Conference

EXTON, Pa., May 1 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Bank of America 2008 Health Care conference at The Four Seasons Hotel in Las Vegas, on Tuesday, May 13, 2008.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 11:20 a.m. (ET). To hear the live webcast of the Kensey Nash presentation at the Bank of America conference, go to http://www.veracast.com/webcasts/bas/healthcare08/id13108295.cfm and access the conference link. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 11:20 a.m. (ET) on Tuesday, May 13, 2008.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

SOURCE Kensey Nash Corporation

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.